News

Can STI continue its defiant climb in second half of 2025?
Bulls say stars are aligned for Singapore but at least one observer recommends taking profit. Read more at straitstimes.com.
PipelineReview.com18h
Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs
Restructuring pipeline to focus on AAV cardiovascular platform (Danon disease, PKP2-ACM, BAG3-DCM) and regulatory activities for KRESLADI™ (severe LAD-I), ...